BR112017024123A2 - construtos de expressão e métodos de manipulação por engenharia genética de levedura metilotrófica - Google Patents

construtos de expressão e métodos de manipulação por engenharia genética de levedura metilotrófica

Info

Publication number
BR112017024123A2
BR112017024123A2 BR112017024123-4A BR112017024123A BR112017024123A2 BR 112017024123 A2 BR112017024123 A2 BR 112017024123A2 BR 112017024123 A BR112017024123 A BR 112017024123A BR 112017024123 A2 BR112017024123 A2 BR 112017024123A2
Authority
BR
Brazil
Prior art keywords
methylilotrophic
yeast
genetic engineering
expression constructs
manipulation methods
Prior art date
Application number
BR112017024123-4A
Other languages
English (en)
Inventor
SHANKAR Smita
Andrew Hoyt Martin
Original Assignee
Impossible Foods Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57249545&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112017024123(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Impossible Foods Inc. filed Critical Impossible Foods Inc.
Publication of BR112017024123A2 publication Critical patent/BR112017024123A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

a presente invenção refere-se a métodos e materiais para manipulação por engenharia genética de levedura metilotrófica.
BR112017024123-4A 2015-05-11 2016-05-11 construtos de expressão e métodos de manipulação por engenharia genética de levedura metilotrófica BR112017024123A2 (pt)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US201562159899P 2015-05-11 2015-05-11
US62/159,899 2015-05-11
US201562183074P 2015-06-22 2015-06-22
US62/183,074 2015-06-22
US201562185921P 2015-06-29 2015-06-29
US62/185,921 2015-06-29
US201562203052P 2015-08-10 2015-08-10
US62/203,052 2015-08-10
US201562220366P 2015-09-18 2015-09-18
US62/220,366 2015-09-18
US201562222388P 2015-09-23 2015-09-23
US62/222,388 2015-09-23
US201562236506P 2015-10-02 2015-10-02
US62/236,506 2015-10-02
US201662313491P 2016-03-25 2016-03-25
US62/313,491 2016-03-25
PCT/US2016/031797 WO2016183163A1 (en) 2015-05-11 2016-05-11 Expression constructs and methods of genetically engineering methylotrophic yeast

Publications (1)

Publication Number Publication Date
BR112017024123A2 true BR112017024123A2 (pt) 2018-08-07

Family

ID=57249545

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017024123-4A BR112017024123A2 (pt) 2015-05-11 2016-05-11 construtos de expressão e métodos de manipulação por engenharia genética de levedura metilotrófica

Country Status (21)

Country Link
US (5) US10689656B2 (pt)
EP (2) EP3294762B1 (pt)
JP (4) JP6831797B2 (pt)
KR (3) KR102504198B1 (pt)
CN (1) CN107614516A (pt)
AU (3) AU2016262494B2 (pt)
BR (1) BR112017024123A2 (pt)
CA (1) CA2985641A1 (pt)
DK (1) DK3294762T3 (pt)
ES (1) ES2908463T3 (pt)
HK (1) HK1252605A1 (pt)
HR (1) HRP20220299T1 (pt)
HU (1) HUE058104T2 (pt)
LT (1) LT3294762T (pt)
MX (3) MX2017014469A (pt)
NZ (1) NZ737094A (pt)
PL (1) PL3294762T3 (pt)
PT (1) PT3294762T (pt)
RS (1) RS63099B1 (pt)
SI (1) SI3294762T1 (pt)
WO (1) WO2016183163A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE058104T2 (hu) 2015-05-11 2022-07-28 Impossible Foods Inc Expressziós konstrukciók és eljárások a metilotróf élesztõ genetikai módosítására
EP3568408A4 (en) 2017-01-13 2020-12-16 Bolt Threads, Inc. ELASTOMER PROTEINS
WO2018140654A1 (en) * 2017-01-25 2018-08-02 Altius Institute For Biomedical Sciences Methods and platform of designing genetic editing tools
WO2019060759A1 (en) 2017-09-21 2019-03-28 Dana-Farber Cancer Institute, Inc. ISOLATION, PRESERVATION, COMPOSITIONS AND USES OF PLANT EXTRACTS JUSTICIA
US11051532B2 (en) 2017-09-22 2021-07-06 Impossible Foods Inc. Methods for purifying protein
US10221403B1 (en) * 2018-04-25 2019-03-05 Life Rainbow Biotech Co., Ltd. Method of preparing zearalenone hydrolase
CN108913732B (zh) * 2018-07-31 2022-02-08 华东理工大学 一种莫纳可林j异源生产的方法及应用
CN111286520B (zh) * 2018-12-10 2021-05-07 上海凯赛生物技术股份有限公司 用于发酵生产l-赖氨酸的重组dna、菌株及其应用
CN109749948A (zh) * 2019-03-05 2019-05-14 天津科技大学 一种利用tef1启动子调控黏玉米谷氨酰胺转氨酶表达的重组毕赤酵母菌株及构建方法
CN109929769B (zh) * 2019-03-05 2021-07-23 天津科技大学 一种利用fld1启动子调控黏玉米谷氨酰胺转氨酶表达的重组毕赤酵母菌株及构建方法
US11427932B2 (en) 2019-04-17 2022-08-30 Impossible Foods Inc. Materials and methods for protein production
AU2020263580A1 (en) 2019-04-25 2021-11-18 Impossible Foods Inc. Strains and methods for production of heme-containing proteins
US20230220328A1 (en) 2019-11-27 2023-07-13 Evelo Biosciences, Inc. Methods and compositions for culturing hemoglobin-dependent bacteria
EP4090746A4 (en) * 2020-01-10 2024-01-24 Intron Biotechnology Inc METHOD FOR PRODUCING SOY LEGHHEMOGLOBIN USING ESCHERICHIA COLI
US10947552B1 (en) 2020-09-30 2021-03-16 Alpine Roads, Inc. Recombinant fusion proteins for producing milk proteins in plants
EP4222167A1 (en) 2020-09-30 2023-08-09 Nobell Foods, Inc. Recombinant milk proteins and food compositions comprising the same
US10894812B1 (en) 2020-09-30 2021-01-19 Alpine Roads, Inc. Recombinant milk proteins
WO2022072846A2 (en) 2020-10-02 2022-04-07 Impossible Foods Inc. Transgenic plants with altered fatty acid profiles and upregulated heme biosynthesis
WO2022072833A2 (en) 2020-10-02 2022-04-07 Impossible Foods Inc. Expression constructs and methods of genetically engineering cells
AU2021391607A1 (en) * 2020-12-02 2023-06-29 Planeat Foods Pte. Ltd. Method of producing globin polypeptide recombinantly and meat substitute food product
WO2022251166A2 (en) 2021-05-25 2022-12-01 Evelo Biosciences, Inc. Bacterial compositions comprising soy hemoglobin
AU2022369299A1 (en) 2021-10-19 2024-03-14 Eat Scifi Inc. Plant base/animal cell hybrid meat substitute
AU2022415449A1 (en) * 2021-12-16 2024-05-23 Impossible Foods Inc. A genetic factor to increase expression of recombinant proteins
US11931687B2 (en) 2022-02-15 2024-03-19 Streamline Innovations, Inc. Gas purification apparatus and method
KR20230164436A (ko) 2022-05-25 2023-12-04 한화솔루션 주식회사 야생형 효모 균주를 이용한 헴 고생산 방법

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
DK162399C (da) 1986-01-28 1992-03-23 Danisco Fremgangsmaade til ekspression af gener i baelgplanteceller, dna-fragment, rekombineret dna-fragment samt plasmid til brug ved udoevelsen af fremgangsmaaden
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US6946587B1 (en) 1990-01-22 2005-09-20 Dekalb Genetics Corporation Method for preparing fertile transgenic corn plants
US5204253A (en) 1990-05-29 1993-04-20 E. I. Du Pont De Nemours And Company Method and apparatus for introducing biological substances into living cells
US5753465A (en) 1994-08-30 1998-05-19 Carnegie Mellon University Unmodified recombinant human adult hemoglobin production
US5538800A (en) 1994-09-29 1996-07-23 At&T Corp. Magnetoresistive oxide material and articles comprising the material
FR2736930B1 (fr) 1995-07-17 1997-09-19 Biocem Procede de production, par des cellules vegetales, de proteines heminiques, proteines ainsi obtenues et produits contenant ces proteines
US5824511A (en) 1995-08-01 1998-10-20 University Technology Corporation Method for enhancing the production of hemoproteins
WO1997047746A1 (en) 1996-06-10 1997-12-18 Novo Nordisk Biotech, Inc. A method for increasing hemoprotein production in filamentous fungi
JP3794760B2 (ja) 1996-07-30 2006-07-12 三井化学株式会社 フィターゼ生産酵母
US5959187A (en) 1996-09-26 1999-09-28 Bailey; James E. Expression of oxygen-binding proteins in plants
JPH10117776A (ja) 1996-10-22 1998-05-12 Japan Tobacco Inc インディカイネの形質転換方法
US7803765B2 (en) 1999-05-05 2010-09-28 Phylogica Limited Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
AU2001292749A1 (en) 2000-09-18 2002-03-26 Genencor International, Inc. Twin-arginine translocation in bacillus
US8021695B2 (en) 2002-02-15 2011-09-20 Arch Personal Care Products, L.P. Personal care composition containing leghemoglobin
ATE520781T1 (de) 2002-12-23 2011-09-15 Max Planck Gesellschaft Verfahren zur veränderung des gehalts von speicherstoffen in pflanzen
CA2525493C (en) 2003-04-11 2018-10-30 Ventria Bioscience Human blood proteins expressed in oryza seeds
KR100660539B1 (ko) 2004-07-29 2006-12-22 삼성전자주식회사 자기 기억 소자 및 그 형성 방법
JP5225087B2 (ja) 2005-08-24 2013-07-03 ザ スクリプス リサーチ インスティチュート 翻訳エンハンサーエレメント依存性のベクター系
JP2008017733A (ja) 2006-07-11 2008-01-31 Tokyo Univ Of Agriculture 異種タンパク質の発現方法及び異種タンパク質の発現方法により得られたタンパク質
JP2008017774A (ja) * 2006-07-13 2008-01-31 Nipro Corp ピキア酵母を用いた組換えヒトヘモグロビンの製造
DK2106447T3 (da) 2007-01-26 2013-06-24 Novozymes As Fremgangsmåde til methanoluafhængig induktion fra methanolinducerbare promotorer i Pichia
EP2573178A3 (en) 2007-07-10 2013-07-24 Monsanto Technology LLC Transgenic plants with enhanced agronomic traits
EP2058398A1 (en) * 2007-11-09 2009-05-13 Nipro Corporation Production of recombinant human hemoglobin using pichia yeast
US9085766B2 (en) 2010-05-21 2015-07-21 Cornell University Methods of producing recombinant heme-binding proteins and uses thereof
EP2601297B1 (en) 2010-08-02 2020-09-16 Cellectis Method for targeted genomic events in algae
WO2012083424A1 (en) 2010-12-21 2012-06-28 The University Of Western Ontario Novel amino acid linker sequences for ligand immobilization
EP2669375B1 (en) 2011-01-27 2018-10-17 Kaneka Corporation Yeast of the genus pichia modified to express high levels of a mpp1 homolog and process for producing protein
MX2014000469A (es) 2011-07-12 2014-10-17 Maraxi Inc Metodos y composiciones para combustibles.
CN102757976B (zh) * 2012-07-12 2014-10-08 华东理工大学 消除甲醇诱导型启动子单一甲醇碳源依赖性的方法
WO2014045621A1 (ja) 2012-09-19 2014-03-27 国立大学法人大阪大学 肺炎球菌表面タンパク質ａを含む肺炎球菌ワクチン
AU2014205114B2 (en) 2013-01-11 2017-11-16 Impossible Foods Inc. Methods and compositions for affecting the flavor and aroma profile of consumables
DK3044320T3 (da) 2013-09-11 2020-03-16 Impossible Foods Inc Sekretion af hæmholdige polypeptider
CA3185690A1 (en) 2014-03-31 2015-10-08 Impossible Foods Inc. Ground meat replicas
HUE058104T2 (hu) 2015-05-11 2022-07-28 Impossible Foods Inc Expressziós konstrukciók és eljárások a metilotróf élesztõ genetikai módosítására
WO2018102656A1 (en) 2016-12-02 2018-06-07 City Of Hope Producing recombinant products in contained systems
WO2018102721A1 (en) 2016-12-02 2018-06-07 City Of Hope Transgenic plants with upregulated heme biosynthesis
AU2020263580A1 (en) 2019-04-25 2021-11-18 Impossible Foods Inc. Strains and methods for production of heme-containing proteins

Also Published As

Publication number Publication date
AU2022201465A1 (en) 2022-03-24
JP2018515098A (ja) 2018-06-14
JP7308160B2 (ja) 2023-07-13
PT3294762T (pt) 2022-03-21
US9938327B2 (en) 2018-04-10
MX2017014469A (es) 2018-04-10
KR20230031993A (ko) 2023-03-07
KR102229968B1 (ko) 2021-03-22
US20220290166A1 (en) 2022-09-15
PL3294762T3 (pl) 2022-04-25
AU2016262494A1 (en) 2017-11-30
RS63099B1 (sr) 2022-04-29
ES2908463T3 (es) 2022-04-29
US11319544B2 (en) 2022-05-03
US20180371469A1 (en) 2018-12-27
SI3294762T1 (sl) 2022-09-30
EP3294762A4 (en) 2018-10-17
DK3294762T3 (da) 2022-03-14
AU2019250216A1 (en) 2019-11-07
JP2023022042A (ja) 2023-02-14
CA2985641A1 (en) 2016-11-17
EP3294762A1 (en) 2018-03-21
JP2022025068A (ja) 2022-02-09
JP2020096610A (ja) 2020-06-25
EP3294762B1 (en) 2022-01-19
LT3294762T (lt) 2022-04-11
US20170349637A1 (en) 2017-12-07
AU2019250216B2 (en) 2022-03-17
NZ737094A (en) 2019-06-28
HRP20220299T1 (hr) 2022-05-13
EP4039695A1 (en) 2022-08-10
MX2022013540A (es) 2022-11-16
US20170349906A1 (en) 2017-12-07
US10273492B2 (en) 2019-04-30
US20180127764A1 (en) 2018-05-10
JP6831797B2 (ja) 2021-02-17
HUE058104T2 (hu) 2022-07-28
WO2016183163A1 (en) 2016-11-17
HK1252605A1 (zh) 2019-05-31
MX2022006513A (es) 2022-07-11
KR102504198B1 (ko) 2023-02-27
KR20200110469A (ko) 2020-09-23
CN107614516A (zh) 2018-01-19
KR20170138543A (ko) 2017-12-15
US10689656B2 (en) 2020-06-23
AU2016262494B2 (en) 2019-11-07

Similar Documents

Publication Publication Date Title
BR112017024123A2 (pt) construtos de expressão e métodos de manipulação por engenharia genética de levedura metilotrófica
AR101845A1 (es) Anticuerpos anti-her2 e inmunoconjugados
EP4299595A3 (en) Compositions and methods related to engineered fc constructs
BR112019012342A2 (pt) anticorpos il-11
IL263211A (en) Compositions and methods relating to engineered fc constructs
GB2547587A (en) Transgenic mice
EP3201339A4 (en) Targeted augmentation of nuclear gene output
MY181175A (en) Therapeutic hpv16 vaccines
TW201613893A (en) Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
EP3423572A4 (en) METHODS RELATING TO MANIPULATED FC CONSTRUCTS
EA039598B9 (ru) Соединение, нацеленное на ил-23а и фно-альфа, и его применение
MY182924A (en) Enzyme compositions and uses thereof
MX361533B (es) Anticuerpos anti-cd22.
BR112016024191A2 (pt) composições e aplicações agrícolas utilizando compostos minerais
BR112018003741A2 (pt) composições biofarmacêuticas
EP3118315A4 (en) Nucleic acid that inhibits expression of irf5
CL2017000152A1 (es) Derivados de isoindolinona
EP3532105A4 (en) METHOD OF TREATING AUTOIMMUNE DISEASES WITH MODIFIED CD4 T CELLS TO OBTAIN ENDOGENOUS FOXP3 GENE EXPRESSION STABILIZATION
CR20170005A (es) Derivados de insoindolina
MX2017000527A (es) Formulaciones de anticuerpos cristalinos.
MX2021006003A (es) Formulaciones de anticuerpos cristalinos.
MX2016014765A (es) Incremento del rendimiento utilizando soforolipidos.
MX2020012893A (es) Formulaciones de proteinas.
MX2016016233A (es) Anticuerpos anti-lgr5 y sus usos.
CL2017000645A1 (es) Síntesis de ent-progesterona e intermediarios de la misma

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]